» Articles » PMID: 35069120

Mechanism and Prevention of Spiral Ganglion Neuron Degeneration in the Cochlea

Overview
Specialty Cell Biology
Date 2022 Jan 24
PMID 35069120
Authors
Affiliations
Soon will be listed here.
Abstract

Sensorineural hearing loss (SNHL) is one of the most prevalent sensory deficits in humans, and approximately 360 million people worldwide are affected. The current treatment option for severe to profound hearing loss is cochlear implantation (CI), but its treatment efficacy is related to the survival of spiral ganglion neurons (SGNs). SGNs are the primary sensory neurons, transmitting complex acoustic information from hair cells to second-order sensory neurons in the cochlear nucleus. In mammals, SGNs have very limited regeneration ability, and SGN loss causes irreversible hearing loss. In most cases of SNHL, SGN damage is the dominant pathogenesis, and it could be caused by noise exposure, ototoxic drugs, hereditary defects, presbycusis, etc. Tremendous efforts have been made to identify novel treatments to prevent or reverse the damage to SGNs, including gene therapy and stem cell therapy. This review summarizes the major causes and the corresponding mechanisms of SGN loss and the current protection strategies, especially gene therapy and stem cell therapy, to promote the development of new therapeutic methods.

Citing Articles

In vitro generation of spiral ganglion neurons from embryonic stem cells.

Agboola O, Deng M, Hu Z Hum Cell. 2025; 38(3):68.

PMID: 40069509 DOI: 10.1007/s13577-025-01194-y.


Inhibition of the NLRP3 inflammasome attenuates spiral ganglion neuron degeneration in aminoglycoside-induced hearing loss.

Fang J, Li Z, Wang P, Zhang X, Mao S, Li Y Neural Regen Res. 2024; 20(10):3025-3039.

PMID: 39610108 PMC: 11826467. DOI: 10.4103/NRR.NRR-D-23-01879.


Decreasing the physical gap in the neural-electrode interface and related concepts to improve cochlear implant performance.

Vecchi J, Claussen A, Hansen M Front Neurosci. 2024; 18:1425226.

PMID: 39114486 PMC: 11303154. DOI: 10.3389/fnins.2024.1425226.


Suppression of the TGF-β signaling exacerbates degeneration of auditory neurons in kanamycin-induced ototoxicity in mice.

Nitta Y, Kurioka T, Mogi S, Sano H, Yamashita T Sci Rep. 2024; 14(1):10910.

PMID: 38740884 PMC: 11091189. DOI: 10.1038/s41598-024-61630-1.


Photobiomodulation Can Enhance Stem Cell Viability in Cochlea with Auditory Neuropathy but Does Not Restore Hearing.

Chang S, Kim E, Carpena N, Lee J, Kim D, Lee M Stem Cells Int. 2023; 2023:6845571.

PMID: 38020205 PMC: 10665102. DOI: 10.1155/2023/6845571.


References
1.
Wake M, Hughes E, Poulakis Z, Collins C, Rickards F . Outcomes of children with mild-profound congenital hearing loss at 7 to 8 years: a population study. Ear Hear. 2004; 25(1):1-8. DOI: 10.1097/01.AUD.0000111262.12219.2F. View

2.
Lang H, Schulte B, Goddard J, Hedrick M, Schulte J, Wei L . Transplantation of mouse embryonic stem cells into the cochlea of an auditory-neuropathy animal model: effects of timing after injury. J Assoc Res Otolaryngol. 2008; 9(2):225-40. PMC: 2504604. DOI: 10.1007/s10162-008-0119-x. View

3.
Shibata S, Cortez S, Beyer L, Wiler J, Di Polo A, Pfingst B . Transgenic BDNF induces nerve fiber regrowth into the auditory epithelium in deaf cochleae. Exp Neurol. 2010; 223(2):464-72. PMC: 2864331. DOI: 10.1016/j.expneurol.2010.01.011. View

4.
Takeno S, Wake M, Mount R, Harrison R . Degeneration of spiral ganglion cells in the chinchilla after inner hair cell loss induced by carboplatin. Audiol Neurootol. 1998; 3(5):281-90. DOI: 10.1159/000013800. View

5.
Berglund A, Ryugo D . Neurofilament antibodies and spiral ganglion neurons of the mammalian cochlea. J Comp Neurol. 1991; 306(3):393-408. DOI: 10.1002/cne.903060304. View